These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10173031)

  • 1. Incremental cost-effectiveness ratio of alteplase in patients with acute myocardial infarction in the French setting.
    Pelc A; Dardenne J; Frelon JH; Hanania G
    Pharmacoeconomics; 1997 Jun; 11(6):595-605. PubMed ID: 10173031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarction.
    Barradell LB; Goa KL
    Pharmacoeconomics; 1995 Nov; 8(5):428-59. PubMed ID: 10172669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups.
    Lorenzoni R; Pagano D; Mazzotta G; Rosen SD; Fattore G; De Caterina R; Gensini G
    Eur Heart J; 1998 Oct; 19(10):1518-24. PubMed ID: 9820990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteplase. A reappraisal of its pharmacological properties and therapeutic use in acute myocardial infarction.
    Gillis JC; Wagstaff AJ; Goa KL
    Drugs; 1995 Jul; 50(1):102-36. PubMed ID: 7588083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy in the elderly. Pharmacoeconomic considerations.
    Ramanathan K; Ellis CJ; White HD
    Drugs Aging; 1996 Apr; 8(4):237-44. PubMed ID: 8920173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.
    Gillis JC; Goa KL
    Pharmacoeconomics; 1996 Sep; 10(3):281-310. PubMed ID: 10163575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of treatment strategies for patients suffering acute myocardial infarction in Greece.
    Maniadakis N; Kaitelidou D; Siskou O; Spinthouri M; Liaropoulos L; Fragoulakis B; Hatzikou M; Alexopoulosi D
    Hellenic J Cardiol; 2005; 46(3):212-21. PubMed ID: 15981557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction.
    Kalish SC; Gurwitz JH; Krumholz HM; Avorn J
    J Gen Intern Med; 1995 Jun; 10(6):321-30. PubMed ID: 7562123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study.
    Tung CY; Granger CB; Sloan MA; Topol EJ; Knight JD; Weaver WD; Mahaffey KW; White H; Clapp-Channing N; Simoons ML; Gore JM; Califf RM; Mark DB
    Circulation; 1999 Jan; 99(3):370-6. PubMed ID: 9918523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
    Kent DM; Vijan S; Hayward RA; Griffith JL; Beshansky JR; Selker HP
    J Clin Epidemiol; 2004 Aug; 57(8):843-52. PubMed ID: 15485737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the cost-effectiveness of thrombolytic therapy in acute myocardial infarct using tissue plasminogen activator or streptokinase:the Italian perspective].
    Lorenzoni R; Fattore G; Gensini G
    G Ital Cardiol; 1997 Jul; 27(7):721-6. PubMed ID: 9303862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of thrombolytics: a simplified model.
    Apikoğlu Rabuş S; Izzettin FV; Sancar M; Rabuş MB; Kirma C; Yakut C
    Pharm World Sci; 2005 Jun; 27(3):243-8. PubMed ID: 16096895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study assigns dollar value to alteplase-streptokinase debate.
    Am J Health Syst Pharm; 1995 Aug; 52(15):1600. PubMed ID: 7583819
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.
    Al-Khatib SM; Stebbins AL; Califf RM; Lee KL; Granger CB; White HD; Armstrong PW; Topol EJ; Ohman EM;
    Am Heart J; 2003 Mar; 145(3):515-21. PubMed ID: 12660676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.
    Newby LK; Eisenstein EL; Califf RM; Thompson TD; Nelson CL; Peterson ED; Armstrong PW; Van de Werf F; White HD; Topol EJ; Mark DB
    N Engl J Med; 2000 Mar; 342(11):749-55. PubMed ID: 10717009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction.
    Goel V; Naylor CD
    Can J Cardiol; 1992; 8(1):31-8. PubMed ID: 1617509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents.
    Woo KS; White HD
    Pharmacoeconomics; 1993 Mar; 3(3):192-204. PubMed ID: 10172049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.